Stonepine Capital Management as of Sept. 30, 2020
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 17 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Com New (LGND) | 31.9 | $31M | 322k | 95.32 | |
| Iveric Bio | 13.9 | $13M | 2.4M | 5.64 | |
| Amryt Pharma Ltd - Spnr Sponsored Ads | 9.8 | $9.5M | 765k | 12.36 | |
| Cti Biopharma | 8.4 | $8.1M | 3.8M | 2.15 | |
| Catalyst Biosciences Com New | 6.3 | $6.1M | 1.4M | 4.30 | |
| Diamedica Therapeutics Com New (DMAC) | 5.1 | $4.9M | 1.1M | 4.24 | |
| Strongbridge Biopharma Shs Usd | 4.2 | $4.0M | 1.9M | 2.10 | |
| Antares Pharma | 3.4 | $3.3M | 1.2M | 2.70 | |
| Xoma Corp Com New (XOMA) | 2.9 | $2.8M | 150k | 18.84 | |
| Adamas Pharmaceuticals | 2.8 | $2.7M | 658k | 4.12 | |
| Apollo Endosurgery | 2.5 | $2.4M | 1.4M | 1.69 | |
| Neos Therapeutics | 2.4 | $2.3M | 4.4M | 0.53 | |
| Cumberland Pharmaceuticals (CPIX) | 2.0 | $1.9M | 590k | 3.21 | |
| Chiasma | 1.6 | $1.5M | 350k | 4.30 | |
| Affimed Therapeutics B V | 1.3 | $1.2M | 358k | 3.39 | |
| Interpace Biosciences (IDXG) | 0.9 | $880k | 285k | 3.09 | |
| Progenity | 0.6 | $614k | 68k | 9.02 |
